Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWNF 023 is a purinergic P2X1 receptor antagonist (IC50 = 0.21 µM).1 It is selective for P2X1 over P2X2-4 receptors (IC50s = >50, 28.9 and >100 µM, respectively). It inhibits α,β-methylene ATP-induced vasoconstriction in isolated rabbit saphenous arteries (pA2 = 5.69).2 NF 023 also inhibits hepatitis C virus (HCV) NS3 helicase (IC50 = 6.2 µM).3
WARNING This product is not for human or veterinary use.
1. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors. Neuropharmacology 38(1), 141-149 (1999).
2. Vasoconstrictor responses via P2X-
3. Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays. Nucleic Acids Res. 40(17), 8607-8621 (2021).